Trial NCT03637764

View at ClinicalTrials.gov 
Org. Study IDs: ACT15377
Secondary IDs: 2018-000390-67 U1111-1202-0839

Last trial update was posted on 2023-07-10

MeSH Interventions

Atezolizumab

MeSH Conditions

Neoplasms

Other Conditions

Neoplasm

Stopping Reasons

Study was stopped after interim analysis for 4 cohorts (HCC, SCCHN, EOC, and GBM) indicated that the results did not fulfill the preplanned interim analysis criteria to move to Phase 2 stage 2 in all 4 cohorts.

Limitations And Caveats

Study was stopped after performance of interim analysis for 4 cohorts (Cohort A [HCC], Cohort B [SCCHN], Cohort C [EOC] & Cohort D-1 [GBM]) as the efficacy results observed in each cohort did not fulfill the pre-planned interim analysis criteria allowing the study to move to Phase 2 Stage 2 in these 4 cohorts.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID